| Nov 7 |
Shareholders Shouldn’t Be Too Comfortable With NCS Multistage Holdings' (NASDAQ:NCSM) Strong Earnings
|
| Nov 5 |
Stonegate Updates Coverage on NCS Multistage Holdings, Inc. (NCSM) 2024 Q3
|
| Nov 1 |
NCS Multistage Holdings Third Quarter 2024 Earnings: Beats Expectations
|
| Nov 1 |
NCS Multistage Holdings, Inc. (NCSM) Q3 2024 Earnings Call Transcript
|
| Nov 1 |
Q3 2024 NCS Multistage Holdings Inc Earnings Call
|
| Nov 1 |
NCS Multistage Holdings Inc (NCSM) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ...
|
| Oct 31 |
NCS Multistage Holdings, Inc. 2024 Q3 - Results - Earnings Call Presentation
|
| Oct 31 |
NRx Pharmaceuticals added to Emerging Growth Conference 76 on October 31 and Update to Schedule
|
| Oct 30 |
NCS Multistage: Q3 Earnings Snapshot
|
| Oct 30 |
NCS Multistage Holdings GAAP EPS of $1.60 beats by $0.33, revenue of $44M beats by $1.2M
|
